Docetaxel and capecitabine in patients with metastatic adenocarcinoma of the stomach and gastroesophageal junction: a phase II study from the North Central Cancer Treatment Group
Titel:
Docetaxel and capecitabine in patients with metastatic adenocarcinoma of the stomach and gastroesophageal junction: a phase II study from the North Central Cancer Treatment Group
Auteur:
Giordano, K.F. Jatoi, A. Stella, P.J. Foster, N. Tschetter, L.K. Alberts, S.R. Dakhil, S.R. Mailliard, J.A. Flynn, P.J. Nikcevich, D.A.